Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

GlaxoSmithKline studies GSK-3117391 for rheumatoid arthritis in phase II trial

Jan. 27, 2017

Mitsubishi Tanabe Pharma discovers MMP-9 production inhibitors

Jan. 25, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

FDA, EMA accept Boehringer Ingelheim's BI-695501 for review

Jan. 19, 2017

Orion presents novel bromodomain-containing protein 4 inhibitors

Jan. 18, 2017

EC grants new orphan drug designation to Corbus' JBT-101

Jan. 18, 2017

Dendright extends collaboration with Janssen and adds Arthritis Queensland as a partner

Jan. 17, 2017

FDA extends NDA review period for baricitinib

Jan. 16, 2017

NeuroVive, Karolinska Institutet enter collaboration for cyclophilin inhibitor

Jan. 13, 2017

Human amniotic mesenchymal stem cell transplantation counteracts bone fragility

Jan. 5, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...